Related Experiment Video
Updated: Oct 4, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Irritable bowel syndrome and diet
1Section of Gastroenterology, Boston University School of Medicine.
A low FODMAP diet effectively reduces symptoms for Irritable Bowel Syndrome (IBS) patients, a common gut-brain disorder. Further research is needed to assess long-term effects and potential nutritional impacts.
Area of Science:
- Gastroenterology
- Dietary Science
- Gut-Brain Axis Research
Background:
- Irritable Bowel Syndrome (IBS) is a prevalent functional gastrointestinal disorder (FGID) causing abdominal pain and altered bowel habits.
- IBS is diagnosed using Rome IV criteria, excluding alarm features.
- Many IBS patients identify food triggers and alter their diet to manage symptoms.
Purpose of the Study:
- To review the role of dietary interventions in managing Irritable Bowel Syndrome (IBS).
- To evaluate the efficacy and implications of a low Fermentable Oligo-, Di-, and Monosaccharides and Polyols (FODMAP) diet in IBS patients.
- To highlight the gut-brain interaction in FGIDs and the impact of diet.
Main Methods:
- Review of recent clinical studies and professional guidelines on dietary interventions for IBS.
- Analysis of the mechanisms by which low FODMAP diets affect gut contents and the gut-brain axis.
- Assessment of reported benefits on IBS symptoms and quality of life.
Main Results:
- Low FODMAP diets have demonstrated significant benefits in reducing IBS symptoms and improving quality of life.
- Dietary interventions modulate luminal gut contents, influencing chemosensing and enteroendocrine cells.
- Professional guidelines now recommend considering a low FODMAP diet for IBS patients.
Conclusions:
- Functional gastrointestinal disorders (FGIDs) like IBS are recognized as gut-brain disorders.
- Low FODMAP diets are effective in alleviating IBS symptoms, as shown in clinical trials.
- Long-term efficacy and potential nutritional side-effects of the low FODMAP diet require further investigation.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

